EGFR and glioblastoma: The combination of auranofin and L-BSO led to synergistic cytotoxic effects across different GBM cell lines, regardless of their EGFR expression status, indicating that targeting GSH synthesis can be a viable strategy to increase the sensitivity of GBM cells to oxidative stress [136].